Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA sequence specificity of mitomycin cross-linking.

S P Teng1, S A Woodson, D M Crothers

  • 1Department of Chemistry, Yale University, New Haven, Connecticut 06511.

Biochemistry
|May 2, 1989
PubMed
Summary

Mitomycins preferentially cross-link CpG DNA sequences, not GpC. This DNA sequence specificity is due to favorable guanine amino group proximity in CpG sites, enhancing cross-linking efficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structures of riboswitch RNA reaction states by mix-and-inject XFEL serial crystallography.

Nature·2016
Same author

Climate change and the integrity of science.

Science (New York, N.Y.)·2010
Same author

Dynamics of biological macromolecules: not a simple slaving by hydration water.

Biophysical journal·2010
Same author

Dynamics of tRNA at different levels of hydration.

Biophysical journal·2009
Same author

RNA folding pathways.

Current protocols in nucleic acid chemistry·2008
Same author

Probing RNA folding pathways by RNA fingerprinting.

Current protocols in nucleic acid chemistry·2008

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Chemical Biology

Background:

  • Mitomycins are a class of bioreductive alkylating agents used in cancer chemotherapy.
  • Their mechanism of action involves DNA cross-linking, but the sequence specificity is not fully understood.

Purpose of the Study:

  • To determine the DNA sequence specificity of N-methylmitomycin A, its aziridinomitosene, and mitomycin C cross-linking.
  • To elucidate the molecular basis for any observed sequence preference.

Main Methods:

  • Gel electrophoresis assays to detect DNA cross-linking.
  • Competition assays to assess non-covalent binding affinities.
  • Molecular modeling to analyze DNA-adduct structural energetics and geometry.

Main Results:

  • N-methylmitomycin A, aziridinomitosene, and mitomycin C preferentially cross-link CpG sites over GpC sites in DNA.
  • Cross-linking yield increases with successive CpG sequences.
  • Molecular modeling suggests favorable guanine amino group positioning in CpG facilitates the second cross-linking step.
  • Mitomycins exhibit equal non-covalent binding to AT and GC sequences, but significant cross-linking only occurs at CpG.
  • N-methylmitomycin A and aziridinomitosene are more potent cross-linking agents than mitomycin C.

Conclusions:

  • The DNA sequence CpG is the preferred target for mitomycin-induced cross-linking.
  • Geometric constraints, specifically the proximity of guanine amino groups in CpG, drive this sequence specificity.
  • Understanding this specificity can inform the design of more effective mitomycin-based therapeutics.

Related Experiment Videos